MichaelGuerreraMD
Pediatric Hematology & Oncology • Washington, DCAssociate Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci
Dr. Guerrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-476-2800
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
University of ConnecticutResidency, Pediatrics, 1995 - 1998- Uconn School Of MedicineClass of 1995
Certifications & Licensure
MD State Medical License 2000 - 2026
VA State Medical License 2021 - 2026
DC State Medical License 1999 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctor Northern Virginia Magazine, 2020
- Top Doctor Washingtonian, 2015-2017, 2019
- Physician of the Year National Hemophilia Foundation, 2018
- Join now to see all
Clinical Trials
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Dec 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- 45 citationsGanglioside GD1a Enhances VEGF-Induced Endothelial Cell Proliferation and MigrationZhihui Lang, Michael F. Guerrera, Riuxiang Li, Stephan Ladisch
Biochemical and Biophysical Research Communications. 2001-04-13 - 62 citationsReal-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.Isabella McCary, Christine Guelcher, Jan G. Kuhn, Regina Butler, Gita Massey
Haemophilia. 2020-04-20 - 16 citationsCatheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thrombopro...Carrie Diamond, Carole Hennessey, Jennifer Meldau, Christine Guelcher, Michael F. Guerrera
The Journal of Pediatrics. 2018-07-01
Abstracts/Posters
- Real-World Use of Emicizumab in Patients with Hemophilia with and without InhibitorsMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab ProphylaxisMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
